| Applications: |
Immunodepletion/Immunocompetition |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Annexin A9 Blocking Peptide is synthetically produced from the 1-100 sequence and is suitable for use in western blot applications. |
| Formulation: |
Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Gene Symbol: |
ANXA9 |
| Gene ID: |
8416 |
| Uniprot ID: |
ANXA9_HUMAN |
| Immunogen Region: |
1-100 |
| Immunogen: |
Synthetic peptide taken within amino acid region 1-100 on human Annexin A9 protein. |
| Tissue Specificity | Expressed in the stratified squamous skin epithelium, but not in epithelia of other types (at protein level). |
| Function | Low affinity receptor for acetylcholine known to be targeted by disease-causing pemphigus vulgaris antibodies in keratinocytes. |
| Peptide Name | Annexin A9Annexin XxxiAnnexin-31Annexin-9Pemphaxin |
| Alternative Peptide Names | Annexin A9 proteinAnnexin Xxxi proteinAnnexin-31 proteinAnnexin-9 proteinPemphaxin proteinANXA9 proteinANX31 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
